SCHEMBL23296264

SCHEMBL23296264

Cc1cnc(C(Cc2ccc(OCc3ccccc3)cc2)NC(=O)O)o1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 5/20 0.47
LTA4H P09960 1/20 0.47
MMP9 P14780 1/20 0.47
MMP8 P22894 1/20 0.47
PPARA Q07869 3/20 0.46
MAOB P27338 1/20 0.46
MME P08473 1/20 0.45
ACE P12821 1/20 0.45
CPA1 P15085 1/20 0.45
ACE2 Q9BYF1 1/20 0.45
FFAR1 O14842 1/20 0.45
FFAR4 Q5NUL3 1/20 0.45
NPC1 O15118 1/20 0.45
ALDH1A1 P00352 1/20 0.45
MAPT P10636 1/20 0.45
PKM P14618 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
PPARD Q03181 1/20 0.45
TACR1 P25103 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23296263 1.00 PPARG (0.47) PPARGLTA4HMMP9MMP8PPARA
SCHEMBL19982211 0.89 ALDH1A1 (0.54) ALDH1A1MAPTPKMRAB9ASMN1; SMN2
SCHEMBL25922304 0.81 SIGMAR1 (0.46) PPARGLTA4HPPARAMAOB
SCHEMBL19982217 0.80 LTA4H (0.51) PPARGLTA4HPPARAMAOBMAPT
Hydrochloric Acid SCHEMBL23296245 0.79 LTA4H (0.50) PPARGLTA4HPPARAMAOBALDH1A1
Hydrochloric Acid SCHEMBL25326756 0.79 LTA4H (0.50) PPARGLTA4HPPARAMAOBALDH1A1
SCHEMBL18435448 0.79 ALDH1A1 (0.61) ACEALDH1A1MAPTPKMRAB9A
SCHEMBL16254386 0.79 ALDH1A1 (0.61) ACEALDH1A1MAPTPKMRAB9A
SCHEMBL19975167 0.78 IDH1 (0.47) MAOBFFAR1NPC1ALDH1A1MAPT
SCHEMBL3550137 0.77 FFAR1 (0.53) FFAR1P4HTM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11530182-B2 YAP1 inhibitors that target the interaction of YAP1 with Oct4 H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) 2022-12-20 US disclosed
US-20210130297-A1 YAP1 INHIBITORS THAT TARGET THE INTERACTION OF YAP1 WITH OCT4 H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. 2021-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210130297-A1 YAP1 INHIBITORS THAT TARGET THE INTERACTION OF YAP1 WITH OCT4 YAP1, YES1, MYC PPARG 3840/4885LTA4H 4843/4885MMP9 4193/4885
US-11530182-B2 YAP1 inhibitors that target the interaction of YAP1 with Oct4 YAP1, YES1, MYC PPARG 3840/4885LTA4H 4843/4885MMP9 4193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.